Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 hereof in relation to its investment in the Shares.
Appears in 8 contracts
Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Babyuniverse, Inc.), Subscription Agreement (Autobytel Inc)
Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s 's examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 hereof in relation to its investment in the Shares.
Appears in 7 contracts
Samples: Subscription Agreement (CDSS Wind Down Inc), Subscription Agreement (CDSS Wind Down Inc), Subscription Agreement (Knot Inc)
Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 5.6 hereof in relation to its investment in the SharesNotes and Warrants.
Appears in 5 contracts
Samples: Subscription and Security Agreement (Regen Biologics Inc), Subscription and Security Agreement (Regen Biologics Inc), Subscription and Security Agreement (Regen Biologics Inc)
Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent it has deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s 's examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 hereof in relation to its investment in the Shares.
Appears in 4 contracts
Samples: Subscription Agreement (Lendingtree Inc), Subscription Agreement (Lendingtree Inc), Subscription Agreement (Lendingtree Inc)
Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 5.7 hereof in relation to its investment in the SharesNotes.
Appears in 3 contracts
Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 hereof in relation to its investment in the SharesShares and Warrants.
Appears in 3 contracts
Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 4.6 hereof in relation to its investment in the Shares.
Appears in 3 contracts
Samples: Stock Purchase Agreement (Axesstel Inc), Stock Purchase Agreement (Axesstel Inc), Stock Purchase Agreement (Axesstel Inc)
Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 5.7 hereof in relation to its investment in the SharesShares and Warrants.
Appears in 2 contracts
Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 hereof in relation to its investment in the Shares.
Appears in 2 contracts
Samples: Subscription Agreement (Ener1 Inc), Subscription Agreement (Ener1 Inc)
Opportunity to Question. The Such Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers from the Issuer’s representatives regarding the terms and conditions of an investment in the Securities and to verify information obtained in the such Investor’s examination of the Issuer, including including, without limitation, the information that the such Investor has received and reviewed as referenced in Section 4.7 hereof in relation to its investment in the SharesSecurities.
Appears in 1 contract
Samples: Subscription Agreement (Patient Safety Technologies, Inc)
Opportunity to Question. The Each Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the such Investor’s examination of the Issuer, including the information that the such Investor has received and reviewed as referenced in Section 4.7 5.7 hereof in relation to its investment in the Shares.
Appears in 1 contract
Opportunity to Question. The Investor has had the opportunity to ------------------------- question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s 's examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 hereof in relation to its investment in the Shares.
Appears in 1 contract
Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s 's examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 hereof in relation to its investment in the SharesShares and the Warrants.
Appears in 1 contract
Samples: Subscription Agreement (Citadel Security Software Inc)
Opportunity to Question. The Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the Investor’s 's examination of the Issuer, including the information that the Investor has received and reviewed as referenced in Section 4.7 hereof hereof, in relation to his, her or its investment in the Shares.
Appears in 1 contract
Opportunity to Question. The Such Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers from the Issuer’s representatives regarding the terms and conditions of an investment in the Securities and to verify information obtained in the such Investor’s examination of the Issuer, including including, without limitation, the information that the such Investor has received and reviewed as referenced in Section 4.7 hereof in relation to its investment in the SharesSecurities.
Appears in 1 contract
Samples: Subscription Agreement (Aeolus Pharmaceuticals, Inc.)
Opportunity to Question. The Such Investor has had the opportunity to question, and has questioned, to the extent deemed necessary or appropriate, representatives of the Issuer so as to receive answers and verify information obtained in the such Investor’s examination of the Issuer, including the information that the such Investor has received and reviewed as referenced in Section 4.7 hereof in relation to its investment in the Shares.
Appears in 1 contract
Samples: Purchase Agreement (Path 1 Network Technologies Inc)
